Page last updated: 2024-08-21

medroxyprogesterone and Carcinoma, Hepatocellular

medroxyprogesterone has been researched along with Carcinoma, Hepatocellular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamiyama, T; Kawamukai, Y; Nagabuchi, E; Nakajima, Y; Ogasawara, K; Sato, N; Sato, Y; Uchino, J; Une, Y1
Abul-Hajj, YJ; Houglum, JE; Morris, HP1

Other Studies

2 other study(ies) available for medroxyprogesterone and Carcinoma, Hepatocellular

ArticleYear
[A case of double cancer of gastric and hepatocellular carcinoma associated with cirrhosis treated by hepatic resection after intra-hepatic arterial infusion chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modality Therapy; Doxorubicin; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Multiple Primary; Stomach Neoplasms; Tamoxifen

1990
Steroid delta 4 -reductase activity in hepatomas of differentgrowth rates.
    Cancer research, 1974, Volume: 34, Issue:5

    Topics: Animals; Carcinoma, Hepatocellular; Cell Division; Enzyme Induction; Liver; Liver Neoplasms; Male; Medroxyprogesterone; Microsomes, Liver; Neoplasms, Experimental; Oxidoreductases; Rats; Testosterone

1974